Affymetrix, Inc. (NASDAQ:AFFX) (the "Company") today announced that the U.S. District Court for the Western District of Wisconsin (the "Court") has granted the company's motion for summary judgment that Affymetrix does not infringe the patents held by Illumina, Inc. (NASDAQ: ILMN), and has directed that the patent infringement lawsuits brought against the company by Illumina regarding U.S. Patent Nos. 7,510,841 and 7,612,020 be dismissed and the cases closed.
"We are pleased with the Court's ruling, which confirms our position that Illumina's lawsuits were without merit," said Rick Runkel, Affymetrix's Executive Vice President, General Counsel and Secretary. "As a biotechnology company that invests significant time, resources and expertise in R&D, we are committed to conducting our business with the utmost integrity and believe that the Court's ruling underscores this commitment."